Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-01 Option Award(A) | 2024-04-05 9:45 pm | N/A 2034-02-28 | Pasithea Therapeutics Corp. | KTTA | Schneiderman Daniel H Chief Financial Officer | 15,927 | $0 | 15,927 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-01 9:46 pm | N/A 2034-02-28 | Pasithea Therapeutics Corp. | KTTA | Schneiderman Daniel H Chief Financial Officer | 15,927 | $0 | 15,927 (Direct) | View |
| 2022-10-11 Option Award | 2022-10-12 8:15 pm | 2023-10-11 2032-10-11 | Pasithea Therapeutics Corp. | KTTA | Schneiderman Daniel H Chief Financial Officer | 300,000 | $0 | 300,000 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-03 9:07 pm | N/A 2032-01-03 | First Wave BioPharma Inc. | FWBI | Schneiderman Daniel H CHIEF FINANCIAL OFFICER | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-06-30 Other | 2021-07-02 5:09 pm | N/A 2030-07-15 | AzurRx BioPharma Inc. | AZRX | Schneiderman Daniel H CHIEF FINANCIAL OFFICER | 285,006 | $0 | 285,006 (Direct) | View |
| 2021-06-30 Option Award | 2021-07-02 5:09 pm | N/A 2031-06-30 | AzurRx BioPharma Inc. | AZRX | Schneiderman Daniel H CHIEF FINANCIAL OFFICER | 285,006 | $0 | 285,006 (Direct) | View |
| 2020-07-16 Other | 2020-07-20 9:51 pm | N/A 2030-01-02 | AzurRx BioPharma Inc. | AZRX | Schneiderman Daniel H CHIEF FINANCIAL OFFICER | 35,006 | $0 | 585,006 (Direct) | View |
| 2020-07-16 Option Award | 2020-07-20 9:51 pm | N/A 2030-07-15 | AzurRx BioPharma Inc. | AZRX | Schneiderman Daniel H CHIEF FINANCIAL OFFICER | 285,006 | $0 | 585,006 (Direct) | View |
| 2020-01-02 Option Award | 2020-01-09 4:10 pm | N/A 2030-01-02 | AzurRx BioPharma Inc. | AZRX | Schneiderman Daniel H CHIEF FINANCIAL OFFICER | 335,006 | $0 | 335,006 (Direct) | View |
Ownership | 2020-01-09 4:05 pm | N/A N/A | AzurRx BioPharma Inc. | AZRX | Schneiderman Daniel H CHIEF FINANCIAL OFFICER | 0 | $0 | 1,000 (Direct) | View |